[European symposium about osteoarthritis in a dog].
Overgaauw
Paul
P
Platform Verantwoord Huisdierenbezit.
D015107:4-Butyrolactone / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D004283:Dog Diseases / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D004285:Dogs; D005060:Europe; D010003:Osteoarthritis / Q000175:diagnosis / Q000473:pathology / Q000628:therapy / Q000662:veterinary*; D026741:Physical Therapy Modalities / Q000662:veterinary*; D013450:Sulfones / Q000627:therapeutic use; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D013450:Sulfones; D015107:4-Butyrolactone; C487384:firocoxib